Pediatrix reports Q3 revenue of $501.4M, up 1.7%
Pontos principais
- Pediatrix Medical Group (NYSE:MD) reported third-quarter 2026 revenue of $501.4 million, up 1.7% year over year, with net income of $47 million.
- Adjusted earnings reached $0.72 per share, along with reported earnings of $0.59 per share, while adjusted EBITDA totaled $85 million.
- CEO Mark S. Ordan said volume and pricing performed ahead of company expectations as Pediatrix continued to pursue operating efficiency and evaluate opportunities in adjacent businesses.
Pediatrix Medical Group (NYSE:MD) reported third-quarter 2026 revenue of $501.4 million, up 1.7% year over year, with net income of $47 million.
Revenue increased from $492.9 million a year earlier, reflecting 1.1% growth in non-same-unit activity and 0.6% growth in same-unit revenue.
Adjusted earnings per share reached $0.72, compared with reported earnings of $0.59 per share, while adjusted EBITDA totaled $85 million.
Same-unit reimbursement-related revenue increased 0.3%, supported by changes in payer mix, higher administrative fees from hospital partners and increased patient acuity, while same-unit patient-volume revenue also grew 0.3%.
Pediatrix said it continued to pursue operating efficiency and evaluate opportunities in adjacent businesses, while recent acquisitions contributed to non-same-unit activity and practice dispositions partly offset that growth.
